Truist Financial’s Bio-Techne TECH Stock Holding History

Truist Financial’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$864K	Sell	12,225 -3,051	-20%	-$165K	﹤0.01%	1865
2026 Q1	$798K	Buy	15,276 +409	+3%	+$24.6K	﹤0.01%	1828
2025 Q4	$874K	Sell	14,867 -575	-4%	-$34.9K	﹤0.01%	1735
2025 Q3	$859K	Sell	15,442 -2,229	-13%	-$119K	﹤0.01%	1749
2025 Q2	$909K	Buy	17,671 +3,060	+21%	+$154K	﹤0.01%	1642
2025 Q1	$857K	Sell	14,611 -5,394	-27%	-$366K	﹤0.01%	1595
2024 Q4	$1.44M	Sell	20,005 -856	-4%	-$62.9K	﹤0.01%	1392
2024 Q3	$1.67M	Sell	20,861 -499	-2%	-$37.5K	﹤0.01%	1310
2024 Q2	$1.53M	Sell	21,360 -479	-2%	-$35.3K	﹤0.01%	1400
2024 Q1	$1.54M	Buy	21,839 +895	+4%	+$64K	﹤0.01%	1413
2023 Q4	$1.62M	Buy	20,944 +867	+4%	+$57.1K	﹤0.01%	1372
2023 Q3	$1.37M	Buy	20,077 +1,786	+10%	+$141K	﹤0.01%	1424
2023 Q2	$1.49M	Sell	18,291 -2,597	-12%	-$209K	﹤0.01%	1389
2023 Q1	$1.55M	Sell	20,888 -5,794	-22%	-$447K	﹤0.01%	1346
2022 Q4	$2.21M	Buy	26,682 +202	+0.8%	+$16K	﹤0.01%	1164
2022 Q3	$1.88M	Sell	26,480 -1,400	-5%	-$121K	﹤0.01%	1209
2022 Q2	$2.42M	Sell	27,880 -4,004	-13%	-$375K	﹤0.01%	1117
2022 Q1	$3.45M	Sell	31,884 -292	-0.9%	-$30.1K	0.01%	1031
2021 Q4	$4.16M	Buy	32,176 +5,324	+20%	+$653K	0.01%	959
2021 Q3	$3.25M	Sell	26,852 -2,152	-7%	-$262K	0.01%	1050
2021 Q2	$3.27M	Sell	29,004 -348	-1%	-$36.6K	0.01%	1060
2021 Q1	$2.8M	Buy	29,352 +612	+2%	+$55.8K	﹤0.01%	1083
2020 Q4	$2.28M	Sell	28,740 -4,000	-12%	-$290K	﹤0.01%	1118
2020 Q3	$2.03M	Buy	32,740 +3,224	+11%	+$210K	﹤0.01%	1064
2020 Q2	$1.95M	Buy	29,516 +3,920	+15%	+$235K	﹤0.01%	1042
2020 Q1	$1.21M	Buy	25,596 +240	+0.9%	+$12K	﹤0.01%	1184
2019 Q4	$1.39M	Buy	25,356 +17,204	+211%	+$903K	﹤0.01%	1297
2019 Q3	$399K	Sell	8,152 -160	-2%	-$8.02K	0.01%	604
2019 Q2	$433K	Sell	8,312 -680	-8%	-$34.3K	0.01%	606
2019 Q1	$446K	Hold	8,992	–	–	0.01%	592
2018 Q4	$325K	Buy	8,992 +4,400	+96%	+$184K	0.01%	627
2018 Q3	$234K	Buy	+4,592	New	+$203K	﹤0.01%	723

Other funds holding TECH

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

BTCPP

Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Truist Financial's TECH Position: Q2 2026 in Review

Truist Financial reduced its Bio-Techne (TECH) stake by 20% in Q2 2026, selling an estimated $165K and leaving 12,225 shares worth $864K. The position accounts for ﹤0.01% of the portfolio, ranked #1865.

Truist Financial first reported a position in TECH in Q3 2018 and has held it in 32 quarters since. The position peaked at $4.16M in Q4 2021. 186 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

Truist Financial held 12,225 shares of Bio-Techne worth $864K as of Q2 2026.
Truist Financial sold 3,051 Bio-Techne shares in Q2 2026, an estimated $165K.
Bio-Techne made up ﹤0.01% of Truist Financial's portfolio in Q2 2026, its #1865 holding.
Truist Financial first reported a position in Bio-Techne in Q3 2018 and has held it in 32 quarters since.
Truist Financial's Bio-Techne position peaked at $4.16M in Q4 2021.
186 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Truist Financial's 13F filing for Q2 2026, filed 28 Jul 2026.